1
Contact Dermatitis, 1998, 38, 180 Copyright C Munksgaard 1998 Printed in Denmark . All rights reserved ISSN 0105-1873 Short Communication Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin M K 1 A K 1 Department of Dermatology, Murayama Hospital, Asashigaoka 1-7-7, Asaka City, Saitama 351, Japan Key words: photosensitivity; lomefloxacin; positive photopatch test; cross-photosensitivity; drug reactions; antibiotics 4-quinolones. C Munksgaard, 1998. A 69-year-old man was seen in June 1997 with erythema, vesicles, and edema on his face and red papules on his dorsal hands that had started a few days before. He had been taking lomefloxacin (LFLX) (Bareon A , Hokuriku Co. Ltd, Fukui, Japan) 200 mg t.d.s. and lysozyme chloride 90 mg t.d.s. orally for rhinitis for 2 weeks. The patient had never taken ciprofloxacin (CPFX) or flerox- acin (FLRX). We performed phototesting as previously described (1) with a Dermaray, Model M-DMR-1 (Eisai Co. Ltd., Tokyo) as light source (2, 3), 4 weeks after the patient stopped taking LFLX and lysozyme chloride. UVB- MED (minimal erythema dose) was normal (60 mJ/ cm 2 ), and irradiation with 13.5 J/cm 2 for UVA produced no response, suggesting that the photosensitivity of the patient had become normal. Patch and photopatch tests were carried out with 10, 1, and 0.1% pet. LFLX, and 10% pet. CPFX, sparfloxacin (SPFX), and FLRX. LFLX (10% and 1%), CPFX (10%), and FLRX (10%) in pet. with UVA-irradiation (4.5 J/cm 2 ) produced ery- thema and small papules with pruritus 1 day after ir- radiation. Patch and photopatch tests with LFLX, CPFX, SPFX, and FLRX in 5 normal subjects showed no erythema or papular response 2 days after appli- cation or 1 day after irradiation. Oral photochallenge test with lysozyme chloride 30 mg and 4.5 J/cm 2 UVA gave no response. Discussion Certain new 4-quinolones, especially enoxacin (ENX) with a naphthyridine ring and SPFX and LFLX with a quinolone ring, are well-known to cause photosensitivity (4–8). Photosensitivity induced by LFLX is thought to be due to both phototoxic and photoallergic mechan- isms (4, 9), photopatch testing with LFLX commonly being negative (10) Cross-photosensitivity to other quinolones has hardly ever been reported (5). An animal study indicated that LFLX had the highest phototoxic potential of the 4-quinolones, also caused photoallergy, and showed no cross-photosensitivity with other 4- quinolones (11). Our patient showed positive photopatch tests to LFLX, CPFX and FLRX, suggesting cross-photosensit- ivity among the 3 quinolones. A complex of quinolone, piperazine, and fluorine residues is presumed to be the antigenic determinant, because it is a structure common to LFLX, CPFX, and FLRX. These 3 quinolones all have a fluorine atom at position 6. A previous report mentions that new quinolones with a fluorine at position 8 readily cause photosensitivity (12), but our case sug- gests that a fluorine at position 6 may also be causal. References 1. Kawada A, Hiruma M, Noguchi H, Kimura M, Ishibashi A, Banba H, Marshall J. Photosensitivity due to sodium ferrous citrate. Contact Dermatitis 1996: 34: 77–78. 2. Kawada A. UVB-induced erythema, delayed tanning, and WA induced immediate tanning in Japanese skin. Photo- dermatol Photoimmunol Photomed 1986: 3: 327–333. 3. Kawada A, Hiruma M, Nakada R, Kukita A. An evalu- ation of broad-spectrum sunscreens against topical PUVA- induced erythema. Acta Dermato-venereologica 1989: 69: 335–337. 4. Gonza ´lez E, Gonza ´lez S. Drug photosensitivity, idiopathic photodermatoses photodermatoses, and sunscreens. J Am Acad Derm 1996: 35: 881–885 5. Correia O. Bullous photodermatosis after lomefloxacin. Arch Dermatol 1994: 130: 808. 6. Kawabe Y, Mizuno N, Sakakibara S. Photoallergic reac- tion induced by enoxaein. Photodermatol Photoimmunol Photomed 1989: 6: 57–60. 7. Kan J S, Kim T H, Park K B, Chung B H, Youn J I. Enoxacin photosensitivity. Photodermatol Photoimmunol Photomed 1993: 9: 159–161. 8. Poh-Fitzpatrick M B. Lomefloxacin photosensitivity. Arch Dermatol 1994: 130: 261. 9. Lietman P S. Fluoloquinolone toxicities. Drugs 1995: 49 (suppl. 2): 159–163. 10. Kurumaji Y, Shono M. Scarified photopatch testing in lo- mefloxacin photosensitivity. Contact Dermatitis 1992: 26: 5–10. 11. Horio T, Miyauchi H, Asada Y, Aoki Y, Harada M. Photo- toxicity and photoallergenicity of quinolones in guinea pigs. J Dermatol Sci 1994: 7: 130–135. 12. Kuwano A, Shoji A, Sugai T. Coexistence of solar urticaria and photosensitive drug eruption due to lomefloxacin. Hifu (in Japanese) 1995: 37: 549–557.

Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin

Embed Size (px)

Citation preview

Page 1: Photosensitivity induced by lomefloxacin with cross-photosensitivity to ciprofloxacin and fleroxacin

Contact Dermatitis, 1998, 38, 180 Copyright C Munksgaard 1998Printed in Denmark . All rights reserved

ISSN 0105-1873

Short CommunicationPhotosensitivity induced by lomefloxacin with cross-photosensitivity to

ciprofloxacin and fleroxacin

M K1 A K

1Department of Dermatology, Murayama Hospital, Asashigaoka 1-7-7, Asaka City, Saitama 351, Japan

Key words: photosensitivity; lomefloxacin; positive photopatch test; cross-photosensitivity; drug reactions; antibiotics4-quinolones. C Munksgaard, 1998.

A 69-year-old man was seen in June 1997 with erythema,vesicles, and edema on his face and red papules on hisdorsal hands that had started a few days before. He hadbeen taking lomefloxacin (LFLX) (BareonA, HokurikuCo. Ltd, Fukui, Japan) 200 mg t.d.s. and lysozymechloride 90 mg t.d.s. orally for rhinitis for 2 weeks. Thepatient had never taken ciprofloxacin (CPFX) or flerox-acin (FLRX).

We performed phototesting as previously described(1) with a Dermaray, Model M-DMR-1 (Eisai Co. Ltd.,Tokyo) as light source (2, 3), 4 weeks after the patientstopped taking LFLX and lysozyme chloride. UVB-MED (minimal erythema dose) was normal (60 mJ/cm2), and irradiation with 13.5 J/cm2 for UVA producedno response, suggesting that the photosensitivity of thepatient had become normal. Patch and photopatch testswere carried out with 10, 1, and 0.1% pet. LFLX, and10% pet. CPFX, sparfloxacin (SPFX), and FLRX.LFLX (10% and 1%), CPFX (10%), and FLRX (10%)in pet. with UVA-irradiation (4.5 J/cm2) produced ery-thema and small papules with pruritus 1 day after ir-radiation. Patch and photopatch tests with LFLX,CPFX, SPFX, and FLRX in 5 normal subjects showedno erythema or papular response 2 days after appli-cation or 1 day after irradiation. Oral photochallengetest with lysozyme chloride 30 mg and 4.5 J/cm2 UVAgave no response.

DiscussionCertain new 4-quinolones, especially enoxacin (ENX)with a naphthyridine ring and SPFX and LFLX with aquinolone ring, are well-known to cause photosensitivity(4–8). Photosensitivity induced by LFLX is thought tobe due to both phototoxic and photoallergic mechan-isms (4, 9), photopatch testing with LFLX commonlybeing negative (10) Cross-photosensitivity to otherquinolones has hardly ever been reported (5). An animalstudy indicated that LFLX had the highest phototoxicpotential of the 4-quinolones, also caused photoallergy,and showed no cross-photosensitivity with other 4-quinolones (11).

Our patient showed positive photopatch tests to

LFLX, CPFX and FLRX, suggesting cross-photosensit-ivity among the 3 quinolones. A complex of quinolone,piperazine, and fluorine residues is presumed to be theantigenic determinant, because it is a structure commonto LFLX, CPFX, and FLRX. These 3 quinolones allhave a fluorine atom at position 6. A previous reportmentions that new quinolones with a fluorine at position8 readily cause photosensitivity (12), but our case sug-gests that a fluorine at position 6 may also be causal.

References1. Kawada A, Hiruma M, Noguchi H, Kimura M, Ishibashi

A, Banba H, Marshall J. Photosensitivity due to sodiumferrous citrate. Contact Dermatitis 1996: 34: 77–78.

2. Kawada A. UVB-induced erythema, delayed tanning, andWA induced immediate tanning in Japanese skin. Photo-dermatol Photoimmunol Photomed 1986: 3: 327–333.

3. Kawada A, Hiruma M, Nakada R, Kukita A. An evalu-ation of broad-spectrum sunscreens against topical PUVA-induced erythema. Acta Dermato-venereologica 1989: 69:335–337.

4. Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathicphotodermatoses photodermatoses, and sunscreens. J AmAcad Derm 1996: 35: 881–885

5. Correia O. Bullous photodermatosis after lomefloxacin.Arch Dermatol 1994: 130: 808.

6. Kawabe Y, Mizuno N, Sakakibara S. Photoallergic reac-tion induced by enoxaein. Photodermatol PhotoimmunolPhotomed 1989: 6: 57–60.

7. Kan J S, Kim T H, Park K B, Chung B H, Youn J I.Enoxacin photosensitivity. Photodermatol PhotoimmunolPhotomed 1993: 9: 159–161.

8. Poh-Fitzpatrick M B. Lomefloxacin photosensitivity. ArchDermatol 1994: 130: 261.

9. Lietman P S. Fluoloquinolone toxicities. Drugs 1995: 49(suppl. 2): 159–163.

10. Kurumaji Y, Shono M. Scarified photopatch testing in lo-mefloxacin photosensitivity. Contact Dermatitis 1992: 26:5–10.

11. Horio T, Miyauchi H, Asada Y, Aoki Y, Harada M. Photo-toxicity and photoallergenicity of quinolones in guineapigs. J Dermatol Sci 1994: 7: 130–135.

12. Kuwano A, Shoji A, Sugai T. Coexistence of solar urticariaand photosensitive drug eruption due to lomefloxacin. Hifu(in Japanese) 1995: 37: 549–557.